Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
94.51
-1.99 (-2.06%)
At close: May 28, 2025, 4:00 PM
94.43
-0.08 (-0.08%)
After-hours: May 28, 2025, 4:00 PM EDT
Merit Medical Systems Revenue
Merit Medical Systems had revenue of $355.35M in the quarter ending March 31, 2025, with 9.84% growth. This brings the company's revenue in the last twelve months to $1.39B, up 8.19% year-over-year. In the year 2024, Merit Medical Systems had annual revenue of $1.36B with 7.89% growth.
Revenue (ttm)
$1.39B
Revenue Growth
+8.19%
P/S Ratio
4.06
Revenue / Employee
$187,616
Employees
7,400
Market Cap
5.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.36B | 99.15M | 7.89% |
Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MMSI News
- 8 days ago - Merit Medical Acquires Biolife Delaware, L.L.C. - GlobeNewsWire
- 22 days ago - Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis - GlobeNewsWire
- 23 days ago - Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial - GlobeNewsWire
- 4 weeks ago - Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Merit Medical Launches the Ventrax™ Delivery System - GlobeNewsWire
- 7 weeks ago - Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025 - GlobeNewsWire
- 2 months ago - Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - GlobeNewsWire
- 2 months ago - Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - GlobeNewsWire